Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
Journal of Medicinal Chemistry|July 20, 2007
Liver-targeted prodrugs of 2'-C-methyladenosine for therapy of hepatitis C virus infectionScott J Hecker, K Raja Reddy, Paul D van Poelje, et al.
Antimicrobial Agents and Chemotherapy|June 2, 2011
Antiviral efficacy upon administration of a HepDirect prodrug of 2'-C-methylcytidine to hepatitis C virus-infected chimpanzeesSteven S Carroll, Kenneth Koeplinger, Marissa Vavrek, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Design, synthesis, and evaluation of prodrugs of ertapenemSheo B Singh, Diane Rindgen, Prudence Bradley, et al.
Antimicrobial Agents and Chemotherapy|January 14, 2026
First-in-human safety and pharmacokinetics of MK-7602, the antimalarial inhibitor of plasmepsins IX/X, in single- and multiple-ascending-dose studiesSusan E Stanley, Russ P Carstens, Maria V Liberti, et al.
Journal of Medicinal Chemistry|November 3, 2009
Identification and biological evaluation of a series of 1H-benzo[de]isoquinoline-1,3(2H)-diones as hepatitis C virus NS5B polymerase inhibitorsJesus M Ontoria, Edwin H Rydberg, Stefania Di Marco, et al.
ACS Infectious Diseases|February 10, 2022
DNA-Dependent Binding of Nargenicin to DnaE1 Inhibits Replication in Mycobacterium tuberculosisMelissa D Chengalroyen, Mandy K Mason, Alessandro Borsellini, et al.
The Journal of Biological Chemistry|January 30, 2003
Inhibition of hepatitis C virus RNA replication by 2'-modified nucleoside analogsSteven S Carroll, Joanne E Tomassini, Michele Bosserman, et al.
ACS Chemical Biology|August 15, 2017
Linking High-Throughput Screens to Identify MoAs and Novel Inhibitors of Mycobacterium tuberculosis Dihydrofolate ReductaseJohn P Santa Maria, Yumi Park, Lihu Yang, et al.
Pageof 11